Home

2010 Press Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.00
Change (%)-0.00 (NaN%)
Volume93,130
Data as of 01/30/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
December 07, 2010
Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
Highlights Include Additional Efficacy Data in Large Animals with Chronic Kidney Disease and New Mechanism of Action Data Presented for the Neo-Kidney Augment(TM) Program EAST NORRITON, Pa., Dec. 7, 2010 /PRNewswire via COMTEX/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that data from the Company's Neo-Kidney Augment(TM), Neo-GI Augment(TM), and Neo-Urinary Conduit(TM) programs are being featured in several posters and oral presentations at the TERMIS N... 
November 23, 2010
Tengion to Present at Piper Jaffray 22nd Annual Health Care Conference
EAST NORRITON, Pa., Nov. 23, 2010 /PRNewswire via COMTEX/ --Tengion, Inc (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010, at 9:30 a.m. EST. A live audio webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TNGN&item_id=3494808 or u...